Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Trxade Group Inc. (MEDS)

MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces Underwriters Exercise of Overallotment Option

Posted on February 24, 2020 by MissionIR

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, today announced the exercise by the underwriters of the Company’s previously announced … Continue reading →

Posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS) | Leave a comment

Trxade Group Inc. (NASDAQ: MEDS) Uplists to Nasdaq, Expects Gross Proceeds of $5.2M from Common Stock Sale

Posted on February 19, 2020 by MissionIR

Trxade announces pricing of a firm commitment public offering of 806,452 shares of its common stock Proceeds to be used as working capital and to fund future acquisitions Company’s B2B online purchasing platform currently has 11,900 pharmacies registered and is … Continue reading →

Posted in Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Closes Firm Commitment Common Stock Offering

Posted on February 19, 2020 by MissionIR

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, on Tuesday announced the closing of its underwritten public offering of 806,452 shares … Continue reading →

Posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS) | Leave a comment